Clinical trials
Learning clinical trials
Below are recruiting learning clinical trials, each written for real people, not researchers. We’re tracking 596 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07373951Enrolling by invitation
Predicting cancer gene status from MRI scans in brain metastasis
This trial uses brain MRI scans and deep learning to predict whether non-small cell lung cancer that has spread to the brain has certain gene changes (EGFR or ALK). Knowing this may help guide treatment without needing additional tissue testing.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07377266Enrolling by invitation
New diabetes clinic for children and families
This study tests a new way of managing diabetes in children that involves the child early in their care, helps families stay calm during treatment, promotes a healthy lifestyle, and connects families with peers for support. The goal is to see if this approach improves outcomes for the whole family.
HerlevAges 3–10 - NCT06841653Recruiting
AI model to predict risk and improve treatment for endometrial cancer
This trial is testing whether a computer model powered by artificial intelligence can better predict outcomes for people with endometrial cancer or related conditions. It uses patient data and tissue samples to see if the model can help doctors choose the best care.
RomeAges 18 years+ - NCT06831357Recruiting
Predicting Cancer Spread in Nasopharyngeal Cancer Using AI
This trial uses a deep learning computer model to look at tissue images and MRI scans to predict whether nasopharyngeal carcinoma may spread to other parts of the body. It may help doctors decide on the best treatment for people with certain stages of this cancer.
Guangzhou, GuangdongAges Any age - NCT07368712Recruiting
Study of kidney function in healthy people and those with kidney issues
This study looks at how the kidneys work in both healthy people and those with reduced kidney function. Researchers want to understand kidney health better to help people in the future.
BerlinAges 18–75 - NCT07363694RecruitingPhase 2/Phase 3
Study of PF-07275315 for moderate to severe COPD
This trial tests a new medicine called PF-07275315 for people with moderate to severe COPD. It aims to see if it can help reduce flare-ups (sudden worsening of symptoms) when added to your usual treatment.
Birmingham, AlabamaAges 35–80 - NCT07345481Recruiting
Learning new connections in brain injury
This study tests whether people with an acquired brain injury can learn new connections between symbols and words using a computer-based learning method. The goal is to see if this approach can help with cognitive rehabilitation.
Arnhem, GelderlandAges 18–75 - NCT07349901Recruiting
Predicting hospital readmission after surgery using smart devices
This trial uses a smartwatch and smart ring to collect health data after elective surgery. The goal is to see if these sensors can help predict who might need to return to the hospital, so doctors can provide better follow-up care.
Manaus, AmazonasAges 18 years+ - NCT07350694Recruiting
Community action to prevent and control type 2 diabetes in Kabul
This trial tests whether a community-led learning and action program can help prevent and control type 2 diabetes and its risk factors in adults. People with normal blood sugar, prediabetes, or diabetes are all welcome to join.
Kabul, KabulAges 20 years+ - NCT07325513Recruiting
Brain stimulation for Gulf War-related pain
This study tests whether a type of brain stimulation (repeated transcranial magnetic stimulation, or rTMS) can help reduce headaches and body pain in veterans with Gulf War Illness. If you are a Gulf War veteran with ongoing moderate-to-severe pain, this trial could help find a new way to manage your symptoms.
San Diego, CaliforniaAges 18–65 - NCT05876598Recruiting
Predict bloodstream infection risk using a computer model
This study builds and tests a computer (machine-learning) model to predict bloodstream infections based on what happens in the first days of care. It may help doctors start the right antibiotic faster for patients who truly have an infection.
RomeAges 18 years+ - NCT07315867Recruiting
EQ training for autistic adults and their learning partners
This trial tests an online emotional intelligence (EQ) training program for autistic adults (ages 18-36) and a trusted learning partner. The goal is to improve social communication, relationships, and accommodation skills.
Wexford, PennsylvaniaAges 18 years+ - NCT07318805RecruitingPhase 1
A study of PF-08032562 for advanced solid tumors
This study tests a new medicine, PF-08032562, for people with advanced breast or colorectal cancer that has not responded to prior treatments. It aims to see if the drug is safe and can help shrink or slow the cancer.
Duarte, CaliforniaAges 18 years+ - NCT07322042Recruiting
Testing a mom-focused app for health checkups
This study tests whether a smartphone app called Moment for Parents helps new mothers stay on top of their health checkups. Researchers want to see if using the app leads to better screening habits compared to a usual-care group.
Ann Arbor, MichiganAges 18 years+ - NCT07316621Recruiting
Crohn's disease risk study for close relatives
This study follows close family members of people with Crohn's disease to see if they develop early signs of the condition. It uses blood tests and checkups to detect Crohn's earlier.
RomaAges 16–35 - NCT05792280Recruiting
AI-assisted endoscopic ultrasound for chest (mediastinal) imaging
This study tests a new computer (deep-learning) system to help interpret images from an endoscopic ultrasound exam of the chest area. It may help make the scan information more consistent and useful for diagnosis.
Changsha, HunanAges 18–80 - NCT07315360RecruitingPhase 1
How a new medicine works in people with reduced kidney function
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
Lake Forest, CaliforniaAges 18–80 - NCT07309107Recruiting
Deep learning study of amyloid pet scans for memory issues
This trial is testing a deep learning tool on amyloid PET scans from patients with memory problems. It aims to improve diagnosis and understanding of Alzheimer's disease.
Vandœuvre-lès-NancyAges 18–99 - NCT07308704Recruiting
Using AI to spot heart muscle disease on echocardiograms
This study at Mayo Clinic is testing an artificial intelligence (AI) tool that analyzes echocardiograms (ultrasound of the heart) to find early signs of four types of heart muscle disease. If the AI flags a high-risk pattern, doctors can learn whether acting on that alert helps catch the condition sooner.
Rochester, MinnesotaAges 18 years+ - NCT07298044RecruitingPhase 4
Switching from tafamidis to acoramidis for heart amyloidosis
This study will see how switching from tafamidis to a newer medicine called acoramidis changes the level of a protein (called transthyretin) in your blood. The goal is to see if acoramidis might work better for people with this type of amyloidosis that affects the heart.
Sankt Pölten, Lower AustriaAges 18–90 - NCT07292532Recruiting
Teaching CPR in Schools: the RCP-KNOW Project
This study tests a new way to teach schoolchildren how to perform CPR (a life-saving technique for when someone stops breathing or their heart stops). It aims to find the best approach to teach these skills in schools.
Cuenca, CuencaAges 5–13 - NCT07293364Recruiting
Study of C1-inhibitor test for hereditary angioedema diagnosis
This study checks if a blood test measuring C1-inhibitor function can help diagnose hereditary angioedema (HAE), a rare condition that causes painful swelling episodes. If you or a close family member have had swelling without rash or itching that lasts 1-5 days and doesn't get better with allergy meds, this trial may be for you.
AlgiersAges 12 years+ - NCT07290036RecruitingPhase 1
Testing different ways to give bimekizumab for psoriatic arthritis or axial spondyloarthritis
This study looks at whether giving bimekizumab in different ways is safe and how it moves through the body over time. It is for adults with active psoriatic arthritis or axial spondyloarthritis who may benefit from bimekizumab treatment.
Peoria, ArizonaAges 18 years+ - NCT07285434Enrolling by invitationEarly Phase 1
Personalized vaccine for first-line advanced lung cancer
This study tests a personalized vaccine (Microlyvaq™) made just for your tumor, given together with standard chemo and immunotherapy (pembrolizumab). It is for people with advanced non-small cell lung cancer who have not yet started treatment for the advanced stage.
Thessaloniki, MacedoniaAges Any age
Hear when a new Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for learning?
- Yes. Clin2 currently lists 596 recruiting learning studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a learning trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a learning trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.